ID
44992
Description
Principal Investigator: Deborah Nickerson, PhD, Department of Genome Sciences, University of Washington, Seattle, WA, USA MeSH: Kabuki syndrome https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000295 The ultimate purpose of this research is to identify genes causing hereditary disorders. We are scaling a new approach to identify the candidate genes and gene mutations that underlie rare human Mendelian (a set of primary tenets relating to the transmission of hereditary characteristics from parent to child) diseases by using exome (protein coding segments of DNA) resequencing. The exome sequences of ten unrelated individuals with a diagnosis of Kabuki Syndrome (OMIM: 147920) were obtained by massively parallel DNA sequencing.
Lien
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000295
Mots-clés
Versions (2)
- 23/06/2022 23/06/2022 - Dr. Christian Niklas
- 12/10/2022 12/10/2022 - Adrian Schulz
Détendeur de droits
Deborah Nickerson, PhD, Department of Genome Sciences, University of Washington, Seattle, WA, USA
Téléchargé le
23 juin 2022
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs000295 Next Generation Mendelian Genetics: Kabuki Syndrome
This subject consent data table contains subject IDs, consent group information, and subject aliases.
- StudyEvent: SEV1
- Eligibility Criteria
- This subject consent data table contains subject IDs, consent group information, and subject aliases.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use.
- This is a subject phenotype table of unrelated subjects who have been diagnosed with Kabuki Syndrome. This table contains measurements for the presence and absence of atrial and ventricular septic defects, aortic coarctation, bicuspid valves, dysrhythmia, spleen/liver/kidney abnormality and dysfunction, hearing loss, preauricular pits tags, cleft and high arched palate, hypotonia, and developmental delay.
- This sample attributes data table includes body site where sample was collected, analyte type, and tumor status.
Similar models
This subject consent data table contains subject IDs, consent group information, and subject aliases.
- StudyEvent: SEV1
- Eligibility Criteria
- This subject consent data table contains subject IDs, consent group information, and subject aliases.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use.
- This is a subject phenotype table of unrelated subjects who have been diagnosed with Kabuki Syndrome. This table contains measurements for the presence and absence of atrial and ventricular septic defects, aortic coarctation, bicuspid valves, dysrhythmia, spleen/liver/kidney abnormality and dysfunction, hearing loss, preauricular pits tags, cleft and high arched palate, hypotonia, and developmental delay.
- This sample attributes data table includes body site where sample was collected, analyte type, and tumor status.
C1257890 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,2])
C0796004 (UMLS CUI [1,2])